Kapoose Creek Bio

Profile

Kapoose Creek Bio is pioneering a new generation of therapeutics by fusing nature’s untapped chemistry with advanced AI discovery. Its lead program, KCB-100, targets Major Depressive Disorder through a novel neurotrophic mechanism, while its ADC payload discovery program expands into oncology with next-generation cytotoxic payloads. Powered by the unEarth Rx AI platform and a world-unique fungal collection, Kapoose Creek Bio is advancing a pipeline of transformative, nature-inspired medicines.

Kapoose Creek Bio logo

Website

kapoosecreek.com

Contact


Event details

Date: January 12 - 14, 2026

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

21 in total